These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1517464)

  • 21. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
    Kanter MH
    Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury.
    Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S
    Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion-associated graft-versus-host disease.
    Ohmori K; Sato H; Furukawa H; Sagara H; Kanno M
    Fukushima J Med Sci; 1993 Dec; 39(2):89-94. PubMed ID: 7927139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery.
    Serefhanoglu K; Turan H; Saba T; Ozer I; Tosun E; Arslan H
    J Natl Med Assoc; 2005 Mar; 97(3):418-20. PubMed ID: 15779510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-associated chronic cutaneous graft-versus-host disease.
    Hull RJ; Bray RA; Hillyer C; Swerlick RA
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 2):327-32. PubMed ID: 7615879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion-associated graft-versus-host disease: a report of three cases in immunocompetent patients in Lebanon.
    Kfoury-Baz E; Alami SY; Nassif RE; Kibbi AG; Rubiez NG; Hannoush HM
    Transfusion; 1996 Mar; 36(3):286-7. PubMed ID: 8604517
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular kinetics of posttransfusion graft-versus-host disease after heart operations.
    Mayumi H; Matsui K; Matsuzaki K; Uchida T; Shinozaki K; Tokunaga K
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):179-82. PubMed ID: 8028366
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-associated graft-versus-graft and potential graft-versus-host disease in a renal allotransplanted patient.
    Andersen CB; Ladefoged SD; Taaning E
    Hum Pathol; 1992 Jul; 23(7):831-4. PubMed ID: 1612582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttransfusion graft-versus-host disease in Japanese newborns.
    Ohto H; Anderson KC
    Transfusion; 1996 Feb; 36(2):117-23. PubMed ID: 8614960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Post-transfusion graft vs. host reaction in aplastic anemia].
    Wechsler A; Magnin PH; Casas JG; Carvani A; Klimosky J
    Med Cutan Ibero Lat Am; 1984; 12(3):203-7. PubMed ID: 6384690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion associated graft versus host disease.
    Tipu HN; Ahmed TA; Khalilullah ; Ahmed S; Satti T; Ahmed P
    J Pak Med Assoc; 2008 Mar; 58(3):143-5. PubMed ID: 18517122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graft versus host disease following transfusion of normal blood products to patients with malignancies.
    Kessinger A; Armitage JO; Klassen LW; Landmark JD; Hayes JM; Larsen AE; Purtilo DT
    J Surg Oncol; 1987 Nov; 36(3):206-9. PubMed ID: 3316850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion-associated graft-versus-host disease.
    Orlin JB; Ellis MH
    Curr Opin Hematol; 1997 Nov; 4(6):442-8. PubMed ID: 9359003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients.
    Ohto H; Anderson KC
    Transfus Med Rev; 1996 Jan; 10(1):31-43. PubMed ID: 8787929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.